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ABSTRACT 
 
 
Metabolic Modeling of Spider Silk in E. coli 
 
 
by 
 
 
Sarah Allred, Master of Science 
 
Utah State University, 2014 
 
 
Major Professor: H. Scott Hinton 
Department: Biological Engineering 
 
 
Spider silk has drawn much attention in recent years because of its many unique and 
remarkable mechanical properties. Great elasticity coupled with high tensile strength, toughness, 
biocompatibility, and biodegradability are all contributing factors to the interest in spider silk for 
medical applications and as a biomaterial. It is not feasible to harvest natural spider silk from 
spiders because of their aggressive and territorial behavior, so recombinant spider silk proteins 
are created in host systems, such as Escherichia coli (E. coli), and the resulting proteins are then 
spun into artificial fibers. However, spider silk production in E. coli is not efficient enough for 
large-scale manufacturing. Metabolic modeling can help assist metabolic engineering methods to 
increase the production of spider silk. A metabolic modeling tool known as dynamic FBA 
correctly predicted the need to increase the ammonium concentration in the cell medium. As a 
result of increasing the ammonium concentration in laboratory fermentors, the spider silk 
production increased significantly. 
 
(93 pages) 
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PUBLIC ABSTRACT 
 
 
Metabolic Modeling of Spider Silk in E. coli 
 
Sarah Allred 
 
 
Spider silk has the potential to be a useful biomaterial due to its high tensile strength and 
elasticity. It is also biocompatible and biodegradable, making it useful for wound dressings and 
sutures, tissue and bone scaffolds, vessels for drug delivery, and ligament and tendon 
replacements. In some studies where spider silk has been used to grow cells, the silk has 
promoted more cell growth than the control. However, it is difficult to obtain the high volume of 
silk needed for these undertakings on a large scale. Spiders are territorial and cannibalistic, so 
they cannot be easily farmed. Therefore, spider silk proteins are frequently produced in other 
organisms. E. coli is often used for spider silk production due to the relative ease of gene 
manipulation and the cost effectiveness of large-scale fermentation. However, due to the large 
protein size of the spider silk and the repeating amino acid motifs, there are some challenges with 
production in E. coli.  
Metabolic modeling is a way to model the metabolism of an organism and can help 
overcome some of the difficulties of spider silk production in E. coli by predicting metabolic 
engineering strategies. In this study, a metabolic modeling tool known as dynamic FBA predicted 
that ammonium is depleted during cell growth. Laboratory results confirmed that by adding 
additional ammonium to the medium, the E. coli cells experienced more cell growth and were 
able to produce more spider silk protein.  
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  INTRODUCTION 
 
 
Spider silk has extraordinary mechanical properties that make it ideal as a biomaterial for 
many applications. Because of the unique combination of high tensile strength and great 
elasticity, spider silk is stronger than steel and can be several times tougher than Kevlar (Griffiths 
& Salanitri, 1980; Agnarsson et al, 2010). It is also biocompatible, biodegradable, and has good 
thermal stability to almost 200°C (Wong Po Foo & Kaplan, 2002; Chung et al, 2012). Studies 
have found recombinant spider silk to be effective as wound dressings, tissue scaffolds, and as 
scaffolds for bone regeneration (Gomes et al, 2011; Widhe et al, 2012). Many other applications 
for spider silk are being considered as well, including parachute cords, composite materials in 
aircrafts, protective clothing against high-velocity projectiles, vessels for drug delivery, and 
coatings for biomedical implants (Xia et al, 2010; Chung et al, 2012). 
Unfortunately, natural spider silk cannot be easily obtained by farming spiders, both 
because of the relatively low levels of silk production and because spiders are highly territorial 
and aggressive (Xia et al, 2010). Instead, recombinant spider silk proteins are created in host 
systems, and the resulting proteins are then spun into artificial fibers. While several organisms 
have been investigated for host systems, including yeast (Fahnestock & Bedzyk, 1997), 
transgenic silkworms (Wen et al, 2010), insect and mammalian cell lines (Lazaris et al, 2002; 
Service, 2002; Zhang et al, 2008), and transgenic plants and animals (Scheller et al, 2001; 
Williams, 2003; Menassa et al, 2004; Xu et al, 2007), one of the most widely employed systems 
for recombinant spider silk protein production is the bacteria Escherichia coli (E. coli) (Chung et 
al, 2012). This is in part because the production of heterologous proteins has already been 
developed for large-scale fermentation in E. coli, making the process less prone to error and more 
cost effective . However, due to the large size of the spider silk proteins, it is difficult to produce 
enough spider silk to be useful.  
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One way to increase the production of spider silk in E. coli is to optimize the cell media. 
However, if modifications to cell media are done without consideration of the consequences to 
the organism, unwanted changes in cellular metabolism can occur. Metabolic modeling can 
predict how factors like media supplements affect the whole metabolic network. Metabolic 
modeling has been shown to be successful in predicting growth rates using a constraint-based 
reconstruction and analysis (COBRA) approach (Price et al, 2003). It can also accurately predict 
what metabolic changes need to be made to optimize the production of bioproducts in organisms 
(Lee et al, 2005; Feist & Palsson, 2008; Kim et al, 2008a, 2008b; Park et al, 2008). Metabolic 
modeling can assist in overcoming the challenges of producing recombinant spider silk proteins 
in E. coli, thus increasing the yield and quality of the bioproduct.  
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LITERATURE REVIEW 
 
 
Spider silk 
 
Spider silk has been a product of interest from antiquity because of its unique mechanical 
properties. These properties have evolved so spiders can build webs to successfully stop rapidly 
flying insects almost instantly, entangling and trapping their prey (Lewis, 2006). The webs of 
orb-weaving spiders are designed to absorb the energy of incoming insects without breaking and 
without bouncing the insect away. The efficiency of spider silk allows orb-weaving spiders to use 
the minimum amount of silk necessary in their webs to catch their prey (Lewis, 2006).  
Spiders are able to produce as many as six different kinds of silk that have different 
tensile strengths and elasticity (Lewis, 2006). The mechanical properties of these silks are tailored 
to their different functions, such as creating different parts of the web, capturing prey with 
adhesive properties, creating the inner egg sac, aiding in reproduction, and acting as a dragline for 
the spider (Wong Po Foo & Kaplan, 2002). Flagelliform silk, formed in the flagelliform gland, 
forms the capture spiral of the web. It is one of the most well studied spider silks because of its 
exceptional mechanical properties (Hayashi & Lewis, 1998, 2001; Higgins et al, 2007).  
 
Mechanical properties 
 
Spider silk is an impressive biomaterial because it combines high tensile strength with 
great elasticity. The tensile strength of flagelliform silk is not as high as that of dragline silk (one 
of the strongest known biological materials), but the elongation is approximately 270% (Gosline 
et al, 1999). The combination of strength and high elasticity give flagelliform silk a greater 
toughness than Kevlar, rubber, silkworm silk, tendon, and bone, as shown in Table 1, which 
summarizes the mechanical properties of different types of spider silk compared with other 
materials. 
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  Table 1.   Mechanical properties of silks and common materialsa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spider silks are also insoluble in most solvents, including water, and dilute acids and 
alkaline materials. They are resistant to digestion from most proteolytic enzymes, which relates to 
the environmental stability of these proteins in fiber form (Wong Po Foo & Kaplan, 2002). Spider 
silks also have good thermal stability to almost 200°C and are biocompatible and biodegradable 
(Wong Po Foo & Kaplan, 2002; Chung et al, 2012). These remarkable properties have sparked 
interest in spider silk as a biomaterial and for medical applications. 
Chemical structure 
 
The reasons behind the unique mechanical properties of spider silk have been elucidated 
in the past several years by studying the chemistry and structure of spider silk. In particular, the 
proteins that comprise the silk and their sequences provide information that directly relates to 
these properties (Lewis, 2006). Spider silks are made of proteins. Except for the sticky material 
deposited on some parts of the web, less than 0.1% of any other compound, including sugars, 
minerals, and lipids, is covalently linked to the silk proteins (Lewis, 2006). The major 
components of flagelliform silk are glycine, proline, alanine, and valine. For more details about 
the amino acid composition of spider silk, see Table 2. 
 
 
 
Material Strength 
(MPa) 
Strain (%) Toughness 
(KJ/kg) 
Dragline silk 4000 35 400 
Minor Ampullate silk 1000 5 30 
Flagelliform 1000 >200 400 
Tubuliform silk 1000 20 100 
Bombyx mori silk 600 20 60 
Kevlar 49 3600 5 30 
Rubber 50 850 80 
Tendon 150 5 5 
Bone 160 3 3 
 aData from Gosline et al, 1999; Lewis, 2006; Altman et al, 2003 
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Table 2.   Amino acid composition (%) of silks from A. diadematus (Andersen, 1970) 
amino acid major ampullate minor ampullate flagelliform aciniform tubuliform 
Asp 1.04 1.91 2.68 8.04 6.26 
Thr 0.91 1.35 2.48 8.66 3.44 
Ser 7.41 5.08 3.08 15.03 27.61 
Glu 11.49 1.59 2.89 7.22 8.22 
Pro 15.77 trace amounts 20.54 2.99 0.59 
Gly 37.24 42.77 44.16 13.93 8.63 
Ala 17.60 36.75 8.29 11.30 24.44 
Val 1.15 1.73 6.68 7.37 5.97 
Ile 0.63 0.67 1.01 4.27 1.69 
Leu 1.27 0.96 1.40 10.10 5.73 
Tyr 3.92 4.71 2.56 1.99 0.95 
Phe 0.45 0.41 1.08 2.79 3.22 
Lys 0.54 0.39 1.35 1.90 1.76 
His trace amounts trace amounts 0.68 0.31 trace amounts 
Arg 0.57 1.69 1.13 4.09 1.49 
 
 
Flagelliform silk is composed of repeating sequences of three different amino acid 
motifs, flanked on either side by a non-repetitive amino-terminal and a carboxy-terminal region, 
as shown in Fig 1. The three repeating units are GPGGX, GGX, and the highly conserved 34 
amino acid spacer region TITEDLDITIDGADGPITISEELTISGA (Lewis, 2006). Most of the 
flagelliform protein sequence is made up of the pentapeptide GPGGX, where X is one of a small 
set of amino acids, usually alanine, valine, serine, or tyrosine. This motif is repeated 40 to 65 
times and most likely forms type II β-turns (Hayashi & Lewis, 2001; Jenkins et al, 2010). The 
shorter subrepeat GGX is then repeated about 8 times, followed by a single occurrence of the 
spacer sequence. The flagelliform gene also contains a pattern of repeating introns that are highly 
conserved across different species. Tandem arrays of the previously mentioned β-turns most 
likely create β-spirals (see Fig 2), which enables flagelliform silk to stretch and recoil (Hayashi & 
Lewis, 2001), while the spacer motifs contribute to the strength of the fiber (Adrianos et al, 
2013). 
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Figure 1.   Schematic diagram of the flagelliform gene structure. The organization is as 
follows:  
A  Sequence of individual protein components.  
B  Protein repeat units.  
C  Intron and exon units of the gene. 
D  Complete gene structure, which is about 30 kb (Lewis, 2006). 
 
 
 
Figure 2.   Amino acid sequence in flagelliform spider silk, made up of tandem repeats of 
the GPGGX unit, where X is usually alanine, valine, serine, or tyrosine.  
A  Here is shown a portion of the translated flagelliform cDNA (Genbank accession 
AF027973).  
B  This molecular model of a GPGGSGPGGY peptide shows how the successive β-turns 
formed from the GPGGX motif likely form β-spirals, creating elasticity in the 
flagelliform fiber (putative fiber axis shown by the arrow) (Hayashi & Lewis, 2001). 
	  
	  
Applications 
 
Because of the biocompatibility and biodegradability of spider silk, there are many 
possible applications in the biomedical field (Rising et al, 2011). Artificial nerve constructs 
partially constructed from dragline spider silk have been able to promote the regeneration of 
peripheral nerves with high functionality in rats (Allmeling et al, 2008). Studies have found 
recombinant spider silk to be effective as wound dressings, tissue scaffolds, and as scaffolds for 
bone regeneration (Gomes et al, 2011; Widhe et al, 2012). In many of these studies, silk has 
promoted cell growth more than the control. In addition to increased cell growth, one study 
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showed that human bone marrow derived mesenchymal stem cells (hMSCs) grown on spider silk 
showed increased calcification, which measures mature bone-related outcomes from the hMSCs 
(Bini et al, 2006). Spider silk can also be modified to contain cell binding sites, such as the amino 
acid sequence RGD, which can further increase cell adherence and proliferation (Wohlrab et al, 
2012). Other proposed biomedical applications are bandages to stop bleeding and promote wound 
healing, sutures for wounds, vessels for drug delivery, coatings for biomedical implants, and 
ligament and tendon replacements (Xia et al, 2010; Chung et al, 2012). 
Many other applications for spider silk are being considered as well because of the 
astonishing and unique mechanical properties. Some of these proposed ideas include parachute 
cords, composite materials in aircrafts, protective clothing against high-velocity projectiles, and 
construction materials (Xia et al, 2010; Chung et al, 2012).  
 
Production process  
 
There has been an increased effort to produce spider silk because of the various industrial 
applications. Unfortunately, natural spider silk cannot be easily obtained by farming spiders, both 
because of the relatively low levels of silk production and because the spiders are highly 
territorial and aggressive (Xia et al, 2010). In recent years, researchers have instead used genetic 
and metabolic engineering to construct, clone, and express native or synthetic genes encoding 
recombinant spider dragline silk proteins (Wong Po Foo & Kaplan, 2002). These proteins are 
then spun into artificial fibers. 
Several host systems have been investigated as platforms for producing recombinant 
spider silk proteins. The production of spider silk in unicellular organisms, particularly in bacteria 
and yeasts, has been studied due to ease and cost effectiveness (Chung et al, 2012). Mammalian 
and insect cell lines have also been studied as potential platforms (Lazaris et al, 2002; 
Huemmerich et al, 2004; Zhang et al, 2008). Transgenic silkworms have been used, as well as 
transgenic plants, such as potato and tobacco plants, and transgenic animals, such as mice and 
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goats (Scheller et al, 2001; Nexia Biotechnologies, unpublished, 2002; Xu et al, 2007). Currently, 
spider silk production in bacteria and yeast seems most viable because the production of 
heterologous proteins has already been developed for large-scale fermentation in these two host 
systems, making the process less prone to error and more cost effective (Wong Po Foo & Kaplan, 
2002). One of the most widely employed systems for recombinant spider silk protein production 
is the bacteria E. coli (Chung et al, 2012).  
It has been found that the molecular weight of the spider dragline silk proteins is 
proportional to the quality of the mechanical properties of the fiber (Xia et al, 2010). Most 
synthetic silk proteins created are much smaller than natural spider silk proteins, which are 
between 250 and over 360 kDa (Chung et al, 2012). However, it has been observed that as the 
size of the recombinant proteins nears the size of the natural silk proteins, the mechanical 
properties of the recombinant spider silk proteins are improved (Xia et al, 2010). It is reasonable 
to assume that the same holds true for flagelliform silk, which is approximately 360 kDa in size 
(Hayashi & Lewis, 1998, 2001). The size of the silk protein affects more than just mechanical 
properties of the final product; one study found that larger sizes of the repetitive core domain of 
flagelliform silk notably increased the solubility in the presence of kosmotropic salt or slightly 
acidic pH, which naturally triggers silk assembly (Heim et al, 2010).  
 
Problems associated with the production process 
 
Since the gene sequences of spider flagelliform silk proteins are highly repetitive and are 
composed of a relatively small set of amino acids, they are difficult to express in E. coli. While 
translating the mRNA, if there are not enough of the needed amino acids or tRNAs, the ribosome 
will stall, and this can result in a prematurely terminated polypeptide chain. Since spider silk 
proteins of a larger molecular weight display improved mechanical properties, this is not ideal.  
The amino acid that poses the largest challenge is glycine. E. coli cells do not normally 
produce copious amounts of glycine; however, glycine is the most commonly occuring amino 
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acid in spider silk proteins. It has also been suggested that because of the highly repetitive amino 
acid sequence of the spider silk gene, DNA deletion in the gene as well as transcriptional and 
translational errors can occur (Chung et al, 2012). Therefore, the spider silk genes are difficult to 
express in E. coli.  
 
Proposed solutions 
 
Metabolic engineering techniques allow several solutions to be proposed to aid with these 
challenges. There are several ways to potentially increase the amount glycine available to the E. 
coli cells, some of which have been suggested and tested recently by Xia et al. (2010). One way is 
to increase the number of tRNAs for glycine by introducing extra tRNA-producing genes into the 
cell. Measures could also be taken to overexpress the serine hydroxymethyltransferase enzyme so 
more serine can be converted into glycine. These methods were shown to be effective in 
producing dragline spider silk proteins with a higher molecular weight, although results of this 
study have yet to be duplicated (Xia et al, 2010). Methods that were not successful included the 
addition of glycine to the culture medium, the inactivation of the glycine cleavage system, and the 
overexpression of glycyl-tRNA synthase, which aminoacylates or charges the amino acid (Xia et 
al, 2010).  
Although it is critical to ensure enough glycine is available, increasing the amount of 
available proline, alanine, and valine could increase spider silk production as well. The metabolic 
engineering approach for increasing these other amino acids would be similar to that of glycine. 
The intracellular production of the amino acids could be increased by either overexpressing the 
metabolic reactions preceding the amino acid, or by systematically knocking out nonessential 
genes to redirect the flow of metabolites through the target amino acid producing reactions. The 
tRNA pools for the amino acids could then be increased by introducing the tRNA genes into E. 
coli, which will allow more amino acids to be made into proteins. During these steps however, 
care should be taken to ensure that the cell does not contain too many non-aminoacylated tRNAs 
	   10	  
at a time because non-aminoacylated tRNAs activate the stringent response, which inhibits rRNA 
and tRNA synthesis. Activation of the stringent response can be avoided by not increasing the 
tRNA pool too rapidly and by making sure there are enough corresponding amino acids to charge 
the tRNAs.  
Additional supplements and nutrients added to the cell media could also increase the 
amount of intracellular amino acids that make up spider silk. Metabolic modeling can be used to 
predict which method is best to produce optimal amounts of spider silk. 
	  
Metabolic reconstructions 
	  
In the mid-1800s, Gregor Mendel carried out a series of experiments that established the 
existence of discrete inherited elements, now called genes, that determine organism function and 
form (Henig, 2000). The relationship between the genetic makeup of a cell (genotype) and the 
organism’s observable characteristics or traits (phenotype) is now a fundamental concept in 
biology. In the decades that followed, it was observed that many traits found in organisms are 
monogenic, meaning they are caused by one gene. However, the vast majority of traits are 
polygenic, meaning they are caused by many genes. The complex nature of polygenic traits can 
make understanding and predicting different phenotypes difficult. 
Whole genome sequences started to become available in 1995 (Fleischmann et al, 1995). 
In principle, this made it possible to identify and characterize all of the genetic elements of an 
organism, although in practice, the function of some genes is still difficult to determine. Using 
these new genetic tools along with biochemical and physiological information, the first genome-
scale metabolic reconstruction of E. coli was created in 2000 (Edwards & Palsson, 2000). Since 
then, metabolic reconstructions have been built for over 100 organisms, including Bacillus 
subtilis, Helicobacter pylori, Pseudomonas aeruginosa, Saccharomyces cerevisiae, and Homo 
sapiens (Feist et al, 2009; Thiele & Palsson, 2010). As new information is gathered, these 
reconstructions are updated to reflect the current metabolic knowledge available on the organism.  
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Metabolic reconstructions use stoichiometric information about biochemical 
transformations taking place in a target organism and represent the totality of the metabolism 
encoded in the genome. There are two parts of a metabolic reconstruction: a database of 
reactions, and a database of metabolites. The reaction database contains a list of all known 
biochemical reactions that take place in the organism, including exchange reactions that transport 
metabolites in and out of the cell and a biomass reaction, representing cell growth. The 
stoichiometrically balanced chemical equations of each reaction are listed, along with each 
reaction's subsystem, reversibility, associated genes and proteins, and upper and lower bounds of 
allowable flux (in mmol gDW-1h-1) through the reaction (see Fig 3). The metabolite database 
contains a list of all metabolites present in each reaction, along with the metabolite charged 
formula and the metabolite charge (see Fig 4). Metabolites present in the extracellular medium, 
periplasm, and cytoplasm are designated by [e], [p], and [c], respectively.  
These reactions of a metabolic reconstruction can be visualized as a network map, as 
shown in Fig 5A. This network map resembles a metabolic map, but has a few key differences: 
every reaction shown is associated with a gene and a genomic location on the genome of the 
target organism, and these network maps are specific to a target genome/organism (Palsson, 2006, 
33–37). Network maps can be represented mathematically using the stoichiometric coefficients in 
each reaction. These can create a connectivity matrix (known as a stoichiometric matrix in the 
case of a metabolic network) that defines the nodes and links in the network.  
A stoichiometric matrix (S matrix) is a systematic way of representing all of the 
stoichiometric coefficients in the network. Each column corresponds to a particular reaction, each 
row corresponds to a particular metabolite, and each numerical element is the corresponding 
stoichiometric coefficient, as shown in Fig 5B (Becker et al, 2007). This mathematical 
representation of a metabolic network sets a mechanistic basis for the genotype-phenotype 
relationship and allows systematic tracing of the consequences of deleting or overexpressing a 
gene. 
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Figure 3.   Portion of reaction database for iECD_1391 model (Monk et al, 2013) 
representing the organism Escherichia coli BL21(DE3) CP001509. Shown are the reactions 
of the citric acid cycle. 
	  
	  
Metabolite	  
name	   Metabolite	  description	  
Metabolite	  charged	  
formula	  
Metabolite	  
charge	  
2dmmq8[c]	   2-­‐Demethylmenaquinone	  8	   C50H70O2	   0	  
2dmmql8[c]	   2-­‐Demethylmenaquinol	  8	   C50H72O2	   0	  
ac[c]	   Acetate	   C2H3O2	   -­‐1	  
accoa[c]	   Acetyl-­‐CoA	   C23H34N7O17P3S	   -­‐4	  
acon-­‐C[c]	   cis-­‐Aconitate	   C6H3O6	   -­‐3	  
adp[c]	   ADP	   C10H12N5O10P2	   -­‐3	  
akg[c]	   2-­‐Oxoglutarate	   C5H4O5	   -­‐2	  
atp[c]	   ATP	   C10H12N5O13P3	   -­‐4	  
cit[c]	   Citrate	   C6H5O7	   -­‐3	  
co2[c]	   CO2	   CO2	   0	  
coa[c]	   Coenzyme	  A	   C21H32N7O16P3S	   -­‐4	  
fum[c]	   Fumarate	   C4H2O4	   -­‐2	  
Figure 4.   Portion of metabolite database for iECD_1391 model (Monk et al, 2013) 
representing the organism Escherichia coli BL21(DE3) CP001509. Shown are some of the 
metabolites in the citric acid cycle. 
Rxn	  name Rxn	  description Formula Gene-­‐reaction	  association Genes Subsystem Reversible LB UB
ACONTa
aconitase	  (half-­‐
reaction	  A,	  Citrate	  
hydro-­‐lyase) cit[c]	  	  <=>	  acon-­‐C[c]	  +	  h2o[c]	   (ECD_00117	  or	  ECD_01253) ECD_00117	  ECD_01253 Citric	  Acid	  Cycle 1 -­‐1000 1000
ACONTb
aconitase	  (half-­‐
reaction	  B,	  Isocitrate	  
hydro-­‐lyase) acon-­‐C[c]	  +	  h2o[c]	  	  <=>	  icit[c]	   (ECD_00117	  or	  ECD_01253) ECD_00117	  ECD_01253 Citric	  Acid	  Cycle 1 -­‐1000 1000
AKGDH
2-­‐Oxogluterate	  
dehydrogenase
coa[c]	  +	  nad[c]	  +	  akg[c]	  	  -­‐>	  
co2[c]	  +	  nadh[c]	  +	  succoa[c]	  
(ECD_00115	  and	  ECD_00685	  and	  
ECD_00686)
ECD_00115	  ECD_00685	  
ECD_00686 Citric	  Acid	  Cycle 0 0 1000
CITL Citrate	  lyase cit[c]	  	  -­‐>	  ac[c]	  +	  oaa[c]	  
((ECD_00583	  and	  ECD_00584	  and	  
ECD_00585)	  and	  ECD_00582)
ECD_00582	  ECD_00583	  
ECD_00584	  ECD_00585 Citric	  Acid	  Cycle 0 0 1000
CS citrate	  synthase
accoa[c]	  +	  oaa[c]	  +	  h2o[c]	  	  -­‐>	  
coa[c]	  +	  h[c]	  +	  cit[c]	   ECD_00680 ECD_00680 Citric	  Acid	  Cycle 0 0 1000
FRD2 fumarate	  reductase
fum[c]	  +	  mql8[c]	  	  -­‐>	  succ[c]	  +	  
mqn8[c]	  
(ECD_04023	  and	  ECD_04024	  and	  
ECD_04025	  and	  ECD_04026)
ECD_04023	  ECD_04024	  
ECD_04025	  ECD_04026 Citric	  Acid	  Cycle 0 0 1000
FRD3 fumarate	  reductase
2dmmql8[c]	  +	  fum[c]	  	  -­‐>	  succ[c]	  
+	  2dmmq8[c]	  
(ECD_04023	  and	  ECD_04024	  and	  
ECD_04025	  and	  ECD_04026)
ECD_04023	  ECD_04024	  
ECD_04025	  ECD_04026 Citric	  Acid	  Cycle 0 0 1000
FUM fumarase fum[c]	  +	  h2o[c]	  	  <=>	  mal-­‐L[c]	  
(ECD_01581	  or	  ECD_01581	  or	  
ECD_01580) ECD_01580	  ECD_01581 Citric	  Acid	  Cycle 1 -­‐1000 1000
ICDHyr
isocitrate	  
dehydrogenase	  
(NADP)
nadp[c]	  +	  icit[c]	  	  <=>	  co2[c]	  +	  
nadph[c]	  +	  akg[c]	   ECD_01134 ECD_01134 Citric	  Acid	  Cycle 1 -­‐1000 1000
MDH
malate	  
dehydrogenase
mal-­‐L[c]	  +	  nad[c]	  	  <=>	  h[c]	  +	  
nadh[c]	  +	  oaa[c]	   ECD_03096 ECD_03096 Citric	  Acid	  Cycle 1 -­‐1000 1000
MDH2
Malate	  
dehydrogenase	  
(ubiquinone	  8	  as	  
acceptor)
q8[c]	  +	  mal-­‐L[c]	  	  -­‐>	  oaa[c]	  +	  
q8h2[c]	   ECD_02137 ECD_02137 Citric	  Acid	  Cycle 0 0 1000
MDH3
Malate	  
dehydrogenase	  
(menaquinone	  8	  as	  
acceptor)
mal-­‐L[c]	  +	  mqn8[c]	  	  -­‐>	  mql8[c]	  +	  
oaa[c]	   ECD_02137 ECD_02137 Citric	  Acid	  Cycle 0 0 1000
MOX malate	  oxidase
mal-­‐L[c]	  +	  o2[c]	  	  <=>	  h2o2[c]	  +	  
oaa[c]	   Citric	  Acid	  Cycle 1 -­‐1000 1000
SUCOAS
succinyl-­‐CoA	  
synthetase	  (ADP-­‐
forming)
atp[c]	  +	  coa[c]	  +	  succ[c]	  	  <=>	  
adp[c]	  +	  pi[c]	  +	  succoa[c]	   (ECD_00687	  and	  ECD_00688) ECD_00687	  ECD_00688 Citric	  Acid	  Cycle 1 -­‐1000 1000
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Figure 5.   Stoichiometric representation of metabolic networks.  
A The first few reactions of glycolysis.  
B  The stoichiometric matrix (S) corresponding to the reactions in a. Each column 
corresponds to a particular reaction, each row corresponds to a particular metabolite, and 
the numerical element is the corresponding stoichiometric coefficient.  
C  The upper (UB) and lower (LB) bounds for each reaction in mmol gDW-1 h-1. The four 
reversible reactions (GLCt1, PGI, FBA, TPI) have lower bounds of -∞. The three 
irreversible reactions (HEX1, PFK, FBP) have lower bounds of zero, because they cannot 
proceed in the reverse direction. The exchange reaction for glucose (EX_glc) has a lower 
bound of -2 mmol gDW-1 h-1, indicating a potential uptake rate for glucose into the cell. 
The upper bound for all reactions is ∞, meaning the reactions are unconstrained in the 
forward direction (Becker et al, 2007). 
 
 
The intracellular environment is crowded and interconnected, placing severe constraints 
on achievable physiological states (Palsson, 2006, 20–21). For example, an average E. coli cell is 
only 1 cubic micron in volume, and in it are about 2,500,000 proteins simultaneously at work (Lu 
et al, 2007; Phillips et al, 2008, 26). These constraints can be modeled in metabolic 
reconstructions using upper and lower bounds, as previously discussed and as shown in Fig 5C. 
These values represent the range of allowable flux (flow of metabolites in mmol gDW-1 h-1) 
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through a reaction; the upper bounds represent the maximum flux allowed in a reaction, and the 
lower bounds represent the minimum amount of flux that can flow through a reaction.  
In addition to metabolic reactions, other reactions can be added to a metabolic 
reconstruction to represent phenomena such as metabolite exchange/transport and biomass 
formation. Exchange reactions allow the simulation of metabolites being added or removed from 
the intracellular environment; exchange reactions with a negative flux value indicate removal 
from the extracellular environment (substrate uptake), while positive flux values indicate the 
addition of metabolites to the extracellular environment (secretion). Changing the lower bounds 
of exchange reactions controls how much of a metabolite can enter the cell. For example, a cell in 
aerobic conditions on a glucose substrate could be modeled by changing both the lower bound of 
the oxygen exchange reaction and the lower bound of the glucose exchange reaction to -20 mmol 
gDW-1 h-1, an uptake value close to that observed in aerobic cultures (Feist et al, 2010). 
The growth rate of a cell can be simulated using a biomass reaction. A biomass reaction 
accounts for all known biomass constituents and their fractional contributions to the overall 
cellular biomass (Thiele & Palsson, 2010). This is obtained by gathering detailed information 
about the chemical composition of the cells, including proteins, RNA, DNA, lipids, 
lipopolysaccharides, peptidoglycan, glycogen, etc. Once the biomass composition is found, a 
stoichiometric reaction is created and scaled so that the flux through it is equal to the exponential 
growth rate (µ) of the organism (Orth et al, 2010). An example of a typical biomass reaction is 
shown in Fig 6. 
 
Flux balance analysis 
 
Flux balance analysis (FBA) is an important tool for harnessing the knowledge encoded 
in these metabolic reconstructions. FBA is a widely used mathematical approach for analyzing 
the flow of metabolites through a metabolic network based on constraints imposed on the model 
(Orth et al, 2010). These constraints, in the form of stoichiometric coefficients and the upper and  
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Figure 6.   The biomass function for the iJO1366 E. coli metabolic reconstruction, the most 
current E. coli reconstruction and the most complete metabolic reconstruction to date (Orth 
& Palsson, 2012). 
 
lower bounds on the flux through each reaction, define the space of allowable flux distribution of 
a system.	  
Once constraints are established, a biological objective is chosen from the reactions in a 
metabolic reconstruction. This objective can be either maximized or minimized. Often, the 
biomass reaction is chosen as the objective function and is maximized to simulate maximum cell 
growth. The mathematical representations of the metabolic reactions in the stoichiometric matrix 
and the biological objective function define a system of linear equations that are solved using 
linear programming. Since there are almost always more reactions (columns in the S matrix) than 
metabolites (rows in the S matrix), there is no unique solution for the system of equations. FBA 
uses constraints in the form of upper and lower bounds to narrow the solution space and optimize 
the objective function. The output for FBA is a list of reactions and their corresponding fluxes 
that optimize the objective function. 
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FBA does not require kinetic parameters and can compute results quickly even for 
relatively large networks (Orth et al, 2010). This feature makes it well suited for studying 
variations in growth conditions such as the use of different substrates, different oxygenation 
levels, and different genetic manipulations. However, FBA has limitations. Because it is a 
constraint-based approach and does not use kinetic parameters, FBA cannot predict metabolite 
concentrations. FBA also operates only under the assumption of steady state conditions, meaning 
the flow of metabolites and model conditions do not change over time, and, except in some 
modified forms, it does not account for the regulation of gene expression or for regulatory effects 
such as activation of enzymes by protein kinases (Orth et al, 2010). 
There are many diverse applications for FBA. FBA used with genome-scale metabolic 
reconstructions can be used for physiological studies, gap-filling efforts, and genome-scale 
synthetic biology (Orth et al, 2010). By changing the lower bounds for exchange reactions for 
different metabolites, cell growth on different media and varying oxygenation levels can be 
modeled. Setting both the upper and lower bounds of a reaction to zero (thus eliminating the 
possibility for flux flowing through the reaction) can simulate a reaction knockout, and using 
genomic and genetic information contained in the metabolic reconstruction relating the different 
reactions to specific genes can simulate gene knockouts. Adding enzymatic reactions to the 
reconstruction can show the effects of gene additions, and constraints can be altered to model the 
overexpression of specific genes.  
Metabolic modeling using FBA has been able to predict cell growth under different 
conditions and has been able to accurately predict what metabolic changes need to be made to 
optimize the production of bioproducts in organisms (Lee et al, 2005; Feist & Palsson, 2008; Kim 
et al, 2008a, 2008b; Park et al, 2008). However, all genome-scale metabolic reconstructions are 
incomplete and contain ‘knowledge gaps’ where reactions are missing (Orth et al, 2010). 
Therefore, modeling results need to be tested in the laboratory. When modeling results do not 
parallel in vivo results, the reconstruction is refined accordingly. Thus, building and using 
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metabolic reconstructions is an iterative process (Thiele & Palsson, 2010). 
 
Dynamic FBA 
  
 Dynamic FBA is a program that utilizes FBA to predict the concentration of extracellular 
metabolites and the growth rate over a series of small time steps. Initial concentration values of 
different extracellular metabolites are specified, as are the number of time steps, and the size of 
the time steps. Beginning with the first time step, the following iterative algorithm predicts 
concentrations for each substrate and the growth rate for all consecutive time steps (Varma & 
Palsson, 1994). 
(i) The substrate concentration (Sc) (mmol/L) is determined from the substrate 
concentration predicted for the previous step (Sco) or from the initial substrate 
concentration if it is the first time step: 𝑆! =   𝑆!" 
(ii) The substrate concentration is scaled to define the amount of substrate available 
per unit of biomass per unit of time (mmol gDW-1h-1): 
𝑆𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒  𝑎𝑣𝑎𝑖𝑙𝑎𝑏𝑙𝑒 =    𝑆!𝑋  ×  ∆𝑡 
where X is the cell density. 
(iii) FBA is then used to calculate the substrate uptake (Su) and the growth rate (µ). 
(iv) Concentrations for the next time step are calculated from the standard differential 
equations: 𝑑𝑋𝑑𝑡 =   𝜇𝑋   → 𝑋 =   𝑋!  ×  𝑒!∆! 𝑑𝑆!𝑑𝑡 =   −𝑆!  ×  𝑋   →   𝑆! =   𝑆!"   +   𝑆!𝜇 𝑋! 1 −   𝑒!∆!  
The output of dynamic FBA is two graphs: one showing the flux through the objective 
reaction over time, and one showing the flux through the exchange reactions for the selected 
metabolites over time. For the dynamic FBA code, see Appendix A.  
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 One downside to dynamic FBA is that at this point, there is no way to account for 
substrates that enter the medium via fed batch mode, so it can only show what becomes of the 
initial concentrations. Another limitation is that dynamic FBA was created to optimize the 
biomass reaction, so there is currently no way to maximize reactions for protein production, or to 
maximize both the growth rate and protein production at the same time. Also, the predicted 
growth rate can sometimes reach values higher than possible because the calculated growth rate is 
constantly in the exponential phase. These aspects make the tool more useful for qualitative rather 
than quantitative study.  
 However, dynamic FBA is a useful tool to understand how substrates are used by the 
organism over time. In one study, dynamic FBA successfully predicted the time profiles of cell 
density, glucose, and fermentation byproduct concentrations (Varma & Palsson, 1994). In cases 
where a recombinant protein is being produced, if the lower bound of flux through the protein 
production is set to a reasonable value, dynamic FBA can be useful for determining which 
metabolites are limiting.   
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MATERIALS AND METHODS 
	  
	  
Metabolic modeling 
 
The iECD_1391 model (Monk et al, 2013) representing the organism Escherichia coli 
BL21(DE3) CP001509 was used in this study. Modeling was done using the COBRA Toolbox, 
(version 2.0.5), with the solver Gurobi (version 5), using Matlab r2013a (version 8.1.0.604).  
 
Medium simulation 
  
 The lower bound of the oxygen exchange reaction was set to -20 mmol gDW-1h-1. This 
has been shown to be the maximum oxygen uptake rate for E. coli cells growing aerobically on a 
variety of carbon sources (Varma et al, 1993). 
Growth on K12 medium was simulated by adjusting lower bounds (in mmol gDW-1h-1) of 
the exchange reactions. Exchange reactions with a negative flux value indicate removal from the 
extracellular environment (substrate uptake), while positive flux values indicate the addition of 
metabolites to the extracellular environment (secretion). The lower bound of glucose was the first 
to be adjusted. The initial glucose concentration in K12 medium is 25 g/L, or 138.89 mmol/L (see 
Table 3 for recipe). Glucose concentrations higher than this can result in the production of the 
fermentation product acetate, which can be toxic to the cells. The specific uptake rate for glucose 
in the media was not available, so an initial study was done to determine what the lower bound of 
the glucose exchange reaction should be. The study showed that when the oxygen exchange 
reaction is set to -20 mmol gDW-1h-1, the maximum value the of the lower bound of the glucose 
exchange reaction without secreting acetate is -11 mmol gDW-1h-1 (see Table 4).  
For each chemical compound in the media, the mass fraction of each constituent was 
found and converted into g/L. For example, there are 4 g/L of dipotassium phosphate. This 
chemical is not in the model, but both potassium and phosphate alone are. There are 1.8 g/L of 
potassium and 2.18 g/L of phosphate. These values were then converted into mmol/L. The only  
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   Table 3.   K12 medium and K12 trace metal solution 
 Chemical Concentration 
K12 Medium: KH2PO4 2 g/L 
 K2HPO4.3H2O 4 g/L 
 (NH4)2HPO4 5 g/L 
 Yeast Extract 5 g/L 
 Glucose 25 g/L 
 MgSO4.7H2O 0.5 g/L 
 Thiamine 2.5 mg/L 
 K12 trace metal 5 ml/L 
   
K12 trace metal solution: NaCl 5 g/L 
 ZnSO4.7H2O 1 g/L 
 MnCl2.4H2O 4 g/L 
 FeCl3.6H2O 4.75 g/L 
 CuSO4.5H2O 0.4 g/L 
 H3BO3 0.575 g/L 
 NaMoO4.2H2O 0.5 g/L 
 6N H2SO4 12.5 ml/L 
 
 
Table 4.   Initial glucose/acetate study  
Flux in mmol gDW-1h-1  
Glucose 
Exchange 
Acetate 
Exchange 
Oxygen 
Exchange 
-15 7.92215 -20 
-14 5.82052 -20 
-13 3.71888 -20 
-12 1.61725 -20 
-11 0 -19.6029 
-10 0 -17.8707 
 
 
chemical in the K12 medium that did not have an exchange reaction in the model was boric acid. 
The metabolite borate (nor boron in any form) is not included in the iECD_1391 model.  
The yeast extract used in the K12 medium is HY-YEST 444 from Kerry (product code 
5Z10313). Like most natural yeast extracts, the composition is undefined, but the product 
information sheet gives the typical amino acid profile (see Fig 7). Using the total amino acid 
concentration (in mg/g), the concentration of each amino acid in the medium in mmol/L was 
calculated. The non-abbreviation Asx means "asparagine or aspartic acid" and Glx means 
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"glutamic acid or glutamine." For these two cases, half of value was added to the total amino acid 
concentration for the two amino acids the abbreviation was associated with. The product 
information sheet for the HY-YEST 444 also listed that the NaCl concentration was 1.0% 
maximum, so an NaCl concentration of 1.0% was also incorporated into the model. 
 
 
Figure 7.   Typical amino acid profile (in mg/g) for HY-YEST 444 (Kerry, Product Code 
5Z10313). 
 
 
Specific uptake rates for each metabolite in the medium were not available, so the values 
for the lower bounds were obtained using the conversion factor138.89 mmol/L = 11 mmol gDW-
1h-1 (12.63 mmol/L = 1 mmol gDW-1h-1), found from converting the concentration of glucose to 
the glucose uptake rate. Although calcium, cobalt, and nickel are not included in the media 
recipe, the model did not produce biomass unless a small amount of flux was allowed to go 
through those exchange reactions. Therefore, the lower bounds of calcium, cobalt, and nickel 
were set to -2.37×10-03, -1.14×10-05, and -1.47×10-04 mmol gDW-1h-1 respectively. Table 5 shows 
all metabolites in the media that are accounted for in the model, the concentration in g/L, the 
concentration in mmol/L, and the calculated uptake rate in mmol gDW-1h-1. Additional nutrients 
are gradually added by the glucose feed, but since the contribution of these nutrients is minimal 
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and not accurately known, only the initial concentrations of nutrients in the K12 medium were 
incorporated into the model.  
 
         Table 5.   Concentration and lower bounds of metabolites in media 
Metabolite MW (g/mol) g/L in media mmol/L in media Lower bound 
(mmol gDW-1h-1) 
Glucose 180.16 25 138.7655417 11 
Ammonium 18.03851 1.365829484 75.71742258 6.002150375 
Phosphate 94.9714 6.655736264 70.08147994 5.555386948 
Potassium 39.0983 1.945099309 49.74894838 3.943619038 
Sulfate 96.07 0.203323529 2.11641021 0.167768684 
Chloride 35.453 0.062050364 1.750214773 0.138740225 
Copper 63.546 0.000509009 0.008010093 0.000634963 
Iron (III) 55.845 0.00490684 0.087865335 0.00696512 
Magnesium 24.305 0.049304203 2.028562155 0.160804933 
Manganese 54.938044 0.005551956 0.101058487 0.008010947 
Molybdate 95.95 0.001826052 0.019031286 0.001508618 
Sodium 22.98976928 0.029775544 1.295164976 0.102668246 
Thiamine 265.35 0.0025 0.009421519 0.000746848 
Zinc 65.38 0.001136847 0.017388304 0.001378378 
Alanine 89.09 0.225 2.525535975 0.200200247 
Arginine 174.2 0.145 0.832376579 0.065982824 
Asparagine 132.12 0.16 1.211020285 0.095998062 
Aspartic acid 133.1 0.16 1.202103681 0.09529124 
Cysteine 121.16 0.02 0.165070981 0.013085243 
Glutamine 146.14 0.345 2.360749966 0.187137594 
Glutamic Acid 147.13 0.345 2.344865085 0.185878393 
Glycine 75.07 0.135 1.798321567 0.14255367 
Histidine 155.15 0.06 0.386722527 0.030655649 
Isoleucine 131.17 0.145 1.105435694 0.08762833 
Leucine 131.17 0.21 1.600975833 0.126909995 
Lysine 146.19 0.22 1.504890895 0.119293303 
Methionine 149.21 0.045 0.301588365 0.02390703 
Phenylalanine 165.19 0.12 0.726436225 0.05758489 
Proline 115.13 0.115 0.998870842 0.079180891 
Serine 105.09 0.13 1.237034922 0.098060253 
Threonine 119.12 0.135 1.133310947 0.089838012 
Tyrosine 181.19 0.09 0.496716154 0.039374888 
Valine 117.15 0.165 1.408450704 0.111648451 
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FlYS3 reaction 
  
 The following reaction simulating the production of FIYS3, a protein made of 3 repeating 
fragments of flagelliform silk, was added to the model: 
120 ala-L[c] + 4 asp-L[c] + 522 gly[c] + 12 his-L[c] + ile-L[c] + lys-L[c] + 2 met-L[c] + 189 pro-
L[c] + 111 ser-L[c] + thr-L[c] + 78 tyr-L[c] + 4476.3 atp[c] + 4476.3 h2o[c] -> 4476.3 adp[c] + 
4476.3 h[c] + 4476.3 pi[c] 
 
This reaction was created by finding the amino acid composition (obtained from Life 
Technologies, see Appendix C), and adding 4.3 ATP per amino acid (with the corresponding 
ADP, phosphate, hydrogen and water) to account for the energy cost of protein synthesis 
(Stephanopoulos et al, 1998, 69). 
 FlYS3 production was simulated by finding the maximum flux through the FlYS3 
reaction under typical conditions, and setting that value as the lower bound.  A growth curve from 
a previous successful fermentation experiment with E. coli BL21(DE3) CP001509 cells 
containing the pET19k-SX-FlYS3 plasmid was obtained (see Fig 8), and the exponential growth 
rate was found using the following equation:  
𝜇 =    𝑙𝑛 2𝑡!  
where 𝜇 = exponential growth rate (h-1) and 𝑡!   = doubling time (h).  
The growth rate was found to be 0.456 g biomass produced gDW-1h-1. Using FBA, the 
media conditions were set, the lower bound of the biomass reaction was set to 0.456 g biomass 
produced gDW-1h-1, and the flux through FlYS3 was optimized. The lower bound through 
iron(III) was not enough to support cell growth, so it was changed from -0.00696512 to -
0.00732381 mmol gDW-1h-1, the minimum amount of flux required to support growth. The 
maximum flux through FlYS3 was found to be 0.00336705 mmol gDW-1h-1, and this value was 
used as the lower bound for the FlYS3 reaction during dynamic FBA simulations. 
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Figure 8.   Previous fermentation experiment with E. coli Bl21(DE3) and pET19K-FlYS3. 
The growth rate was found to be 0.456 g biomass produced gDW-1h-1.  
 
FBA and dynamic FBA 
 
FBA was used for preliminary modeling to determine how much glucose could be added 
without acetate being secreted, which exchange reactions needed flux through them to enable the 
model to run, and the maximum flux through the FlYS3 reaction. See Appendix A for more 
information. 
Dynamic FBA was the primary tool used to analyze the growth rate and production of 
FlYS3. All lower bounds were set as previously described, and the biomass reaction was set as 
the objective function. The initial biomass field (initBiomass) was set to 0.01, the time step size 
(timeStep) was set to 0.5, and the number of time steps (nSteps) was set to 100. All metabolites in 
the media were analyzed.  
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Although a method has been developed to model the metabolic burden of carrying and 
replicating plasmids to the cell (Ow et al, 2009), the specific plasmid synthesis, vital to the 
method, was not known, so this procedure were not used in this study. 
	  
Laboratory experiments 
	  
Cells and cell proliferation 
 
E. coli BL21(DE3) CP001509 cells containing the pET19k-SX-FlYS3 plasmid were used 
in this study. The pET19k-SX-FlYS3 plasmid, a modified form of the pET-19b plasmid, confers 
kanamycin resistance to the cells and contains the sequences for serine hydroxylmethyltransferase 
(SHMT), tRNAs for glycine and two forms of proline (GlyT, ProL, and ProM), and FlYS3, an 
insert made up of 3 multiples of a 1000 bp fragment of flagelliform silk (for more information, 
see Appendix C).  
Unless otherwise noted, just prior to inoculation of all media, kanamycin was added so 
that the final kanamycin concentration was 75 µg/ml. A seed culture of cells was grown by 
inoculating 5 ml of Yeast-Hy ES II medium (see Appendix B for recipe) with around 5 cell 
colonies from an agar plate. The cells were grown in a 15 ml tube at 37°C and 220 rpm for 7.5 
hours. The 5 ml seed culture was then added to 100 ml of Yeast-Hy ES II medium and grown in a 
covered 250 ml baffled flask at 30°C and 220 rpm for 9 hours.  
The 100 ml seed was then transferred to 1.5 liters of K12 medium (see Appendix B for 
recipe) in a 5 liter BioFlo 310 Benchtop Fermentor/Bioreactor. The bioreactor was operated 
according to the user's guide provided by New Brunswick (New Brunswick, 2010). The dissolved 
oxygen was set to 45%, the pH was kept between 6.9 and 7.0, and the temperature was set to 
37°C. The pH was controlled by 10 % NaOH (w/v) in some replicates and by 20% NH4OH (v/v) 
in others. Once the OD measured at a wavelength of 600 nm surpassed 4.0, the glucose feed was 
activated. The glucose feeding solution (see Appendix B for recipe) contained 100 µg/L of 
kanamycin. Glucose levels were monitored using a ReliOn Prime Blood Glucose Monitoring 
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System and were kept between 10 and 25 g/L. Samples of known glucose concentration were 
diluted 1:20 and were measured by the ReliOn Prime Blood Glucose Monitoring System. A 
standard curve was created to convert ReliOn readings to glucose concentration in g/L (see Table 
6 and Fig 9). 
 
      Table 6.   ReliOn reading standard curve 
Glucose % g glucose/L ReliOn Reading g/L from best fit equation 
0.04 0.4 47 0.395646 
0.1 1 141 1.013414 
0.15 1.5 231 1.505534 
0.2 2 361 2.044774 
 
 
	  
Figure 9.   Standard Curve for ReliOn Readings.  
 
Once the OD at 600 nm reached approximately 20, the cells were induced with 1 mM 
IPTG, 0.15 ml of 50 mg/ml kanamycin (7.5 mg in all) was added, and the temperature was 
lowered to 30°C to reduce the occurrence of protein aggregation. Two hours after IPTG 
induction, 0.15 ml of 50 mg/ml kanamycin (7.5 mg in all) was again added. Cells were grown 
until 4 hours after induction. At each time point, supernatant was obtained for various analyses by 
centrifuging samples at 15,000 rpm for 7 minutes, collecting the supernatant, and discarding the 
cell pellet. 
 
Ammonium analysis 
 
The ammonium concentration of the supernatants of the samples at every time point was 
measured using an Ammonium Ion-Selective Electrode from Vernier, which gives readings in 
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units of mg of nitrogen as ammonium per liter. For example, a solution with a concentration of 
100 mg of ammonium per liter would have a concentration (and subsequent reading) of 77.65 mg 
of nitrogen as ammonium per liter. All standards with known concentrations were made using the 
unit mg of nitrogen as ammonium per liter. According to the user's manual, the suggested pH 
range for the electrode is between 4 and 7.5. Because of this, all standards were adjusted so that 
the pH was close to 4.0. All readings were recorded after the electrode had been submerged in the 
sample for 3 minutes. 
The electrode was calibrated using two standards with a concentration of 100 and 1 mg of 
nitrogen as ammonium phosphate per liter. A standard curve was created by measuring the 
ammonium concentration in four standards (100, 75, 50, and 25 mg of nitrogen as ammonium 
phosphate per liter) and plotting those readings against the known concentrations each time 
before measuring the ammonium concentration of samples. Subsequent readings of samples were 
then corrected using the best fit line equation for the generated standard curve. 
According to the user's manual, potassium ions interfere with the electrode's readings. 
Because K12 medium contains potassium, an ammonium reading of unaltered K12 medium with 
the standard amount of ammonium phosphate was compared to that of K12 medium with no 
ammonium phosphate to determine the background readings from the potassium in the medium. 
All samples were measured at a 1:20 dilution, so the media were also measured at a 1:20 dilution, 
the pH adjusted to 4.0. The results showed that the background reading for potassium was 144 
mg/L (See Fig 10).  
The supernatants of the samples were diluted 1:20 with acidic water (pH 3.2). The 
resulting samples had a pH of about 4.0. Once readings were recorded, they were corrected 
according to the best fit line equation for the standards measured prior to sample analysis, the 
value was multiplied by its dilution factor, and the background reading for the potassium (144 
mg/L) was subtracted.  
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Figure 10.   Finding the background reading for the NH4 electrode. 
A  Measured NH4 concentrations of 4 (NH4)2HPO4 standards.  
B  Standard curve generated from NH4 electrode readings of standards.  
C  The NH4 concentration of K12 media with and without NH4 were measured to determine 
the background reading from potassium in the medium. 
 
 
ELISA 
  
 To quantify the protein, an ELISA test was performed on the samples from the last time 
point of each replicate. Prior to the test, all samples were diluted to an OD of 10 with 1X lysis 
buffer. The samples were then sonicated at 150 watts for 20 seconds. After sonication, samples 
were centrifuged at 14,000 rpm for 10 minutes. The supernatant was collected for analysis, and 
the cell pellets were discarded. A set of standards (200, 2000, 10,000, 20,000, 30,000, and 50,000 
ng FlYS3 protein/ml) was also measured, and all samples and standards were analyzed in 
duplicates. A Q-Plex Array: Anti Poly-Histidine kit from Quansys Biosciences was used for the 
ELISA test, along with the accompanying Q-View™ imager and Q-View™ software to analyze 
the plate. The test was performed according to the user's manual (see Appendix B). MasterPlex 
2010 was used to interpret the data.  
 
Western blot 
 
SDS-PAGE and western blot were performed on the samples from the last time point of 
each replicate for protein verification. Prior to the procedure, the samples were prepared exactly 
as they were for the ELISA test: they were diluted to an OD of 10 with 1X lysis buffer, sonicated, 
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and centrifuged so the supernatant could be collected. In 1.5 ml tubes, 25 µl of each sample was 
mixed with 25 µl of 2X SaBU (sample buffer with urea) dye, and the tubes were boiled in a water 
bath for 10 minutes and quickly centrifuged to remove the sample from the lids of the tubes.  
Precise™ Protein Gels from Thermo Scientific were used for SDS-PAGE. 5 µl of 
Precision Plus Protein™ Dual Color Standard from Bio-Rad were loaded into the first lane, and 
20 µl of each sample were loaded into each subsequent lane. Sample loading and running was 
performed according to the Precise™ Protein Gels protocol (see Appendix B) at 100 volts for 60 
minutes.  
The western blot was performed according to the Wet Blotting Protocol (see Appendix 
B), using a nitrocellulose transfer membrane. The transfer was run at 100 mAmps per gel for 60 
minutes.  
The membrane was stained initially using Ponceau dye, then rinsed briefly to ensure the 
protein bands had transferred to the membrane. The membrane was then rinsed thoroughly, and 
20 ml of milk-TBS-Tween mixture (1 gram of powdered milk in 20 ml TBS-Tween) was poured 
over the membrane in a small container. The container was placed on a gently rocking lab shaker. 
After 30 minutes, 5 µl of the antibody Anti-6X-HIS Mouse Epitope Tag was added to the 
container and was allowed to shake for 20 minutes. The membrane was then rinsed twice with 
TBS-Tween, the second time shaking for 5 minutes before discarding the TBS-Tween. Another 
20 ml of milk-TBS-Tween mixture and 5 µl of the antibody Rb pAb to Ms IgG (AP) were then 
added to the container. After shaking for 20 minutes, the membrane was again rinsed with TBS-
Tween, the second time shaking for 5 minutes before discarding the TBS-Tween. Enough 1-Step 
NBT/BCIP to submerge the membrane was then added, and the container was allowed to shake 
for 10 minutes, or until dark bands clearly appeared. Once bands could easily be seen, the 
membrane was rinsed with deionized water and was allowed to dry. 
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RESULTS 
	  
	  
Metabolic modeling 
 
Dynamic FBA revealed that ammonium was the first limiting metabolite. When the 
initial concentration for ammonium was set to 75.72 mmol/L, the maximum growth rate was 4.33 
h-1 (see Fig 11). However, once there was no specific initial concentration for ammonium 
(therefore, it was unlimited), the growth rate was 4.44 h-1, and iron(III) became the limiting 
metabolite (see Fig 12). Fig 13 shows the same data but is zoomed in to view iron(III) depletion. 
 
 
Figure 11.   Dynamic FBA output for all metabolites in K12 medium.  
A When the initial concentration of ammonium was 75.72 mmol/L, the maximum growth 
rate was 4.33 h-1. 
B  The first limiting metabolite was ammonium.  
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Figure 12.   Dynamic FBA output for all metabolites in K12 medium with unlimited  
ammonium.  
A When the initial concentration of iron(III) was 0.09 mmol/L, the maximum growth rate 
was 4.44 h-1. 
B  After ammonium, iron(III) is the limiting metabolite. 
 
 
When the specific initial concentrations for both ammonium and iron(III) were removed 
(making both metabolites essentially unlimited), the maximum growth rate was 6.86 h-1, and 
glucose became the limiting metabolite (see Fig 14). Therefore, according to the results of 
dynamic FBA, the initial concentrations of ammonium and iron(III) will become depleted before 
glucose, thus limiting the growth rate. Although it is beyond the capabilities of dynamic FBA to 
show this, limiting the growth rate also limits protein production. In order to not hinder protein 
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production, ammonium and iron(III) must either be replenished during cell growth or must have 
higher initial concentrations in the medium.	  
 
Figure 13.   Dynamic FBA output for all metabolites in K12 medium with unlimited  
ammonium, zoomed in to view iron(III) depletion.  
A When the initial concentration of iron(III) was 0.09 mmol/L, the maximum growth rate 
was 4.44 h-1. 
B  After ammonium, iron(III) is the limiting metabolite. 
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Figure 14.   Dynamic FBA output for all metabolites in K12 medium, with unlimited  
ammonium and unlimited iron(III).  
A When the initial concentration of glucose is 138.77 mmol/L, the maximum growth rate 
was 6.86 h-1. 
B  After ammonium and iron(III), the limiting metabolite is glucose. 
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Laboratory experiments 
	  
Laboratory experiments were performed to determine the effect of ammonium and 
iron(III) on the production of FlYS3. Three fermentation experiments were performed growing E. 
coli using 10% sodium hydroxide as a pH control. Three additional fermentation experiments 
were performed using 20% ammonium hydroxide as the pH control, to determine if additional 
ammonium increased the production of the FlYS3 protein. The growth curves for the 
fermentation experiments are shown in Fig 15, and the ammonium concentrations are shown in 
Fig 16.  
 
 
Figure 15.   The optical density (OD) at 600 nm over time for E. coli cells grown using 20% 
NH4OH or 10% NaOH as the pH control. 
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Figure 16.   The ammonium concentration over time for E. coli cells grown using 20% 
NH4OH or 10% NaOH as the pH control. 
 
 
 An additional fermentation experiment with a pH control of 20% ammonium hydroxide 
was performed to determine how quickly iron is depleted from the medium.  Preliminary results 
using Agilent 7700x ICP-MS (inductively coupled plasma mass spectroscopy) showed that iron 
was not depleted over time, so no further studies were conducted. 
 A western blot was performed on the samples from the last time point of each 
fermentation experiment to verify the correct protein (FlYS3, 83 kDa) was produced (see Fig 17). 
An ELISA was performed on the samples from the last time point of each fermentation 
experiment to quantify the protein. The ELISA results are shown in Table 7.  
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Figure 17.   A western blot from the last time point of each fermentation experiment. This 
test verifies that the correct protein, FlYS3, 83 kDa was produced in each of the 
fermentation experiments. 
	  
	  
   Table 7.   ELISA results 
Sample  ELISA Reading  Calculated concentration (ng/ml) 
Standard: 200 ng/ml 8984.50 3878.78 
Standard: 2000 ng/ml 8639.00 1768.55 
Standard: 10000 ng/ml 3746.00 10325.83 
Standard: 20000 ng/ml 2190.50 17998.61 
Standard: 30000 ng/ml 1528.50 29278.92 
Standard: 50000 ng/ml 1101.00 67459.07 
NaOH:1 8810.50 1999.25 
NaOH:2 14312.00 0.00 
NaOH:3 14711.50 0.00 
NH4OH:1 6261.00 5410.47 
NH4OH:2 6456.50 5125.83 
NH4OH:3 7518.00 3613.03 
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DISCUSSION 
	  
	  
Interpretation of results 
	  
The metabolic modeling results correctly predicted that ammonium is a limiting 
metabolite. It is clear from the ammonium concentration data that if ammonium is not 
replenished, it will become depleted (see Fig 16). In the samples where 10% NaOH was used as 
the pH control, the ammonium concentration decreases over time and is completely depleted after 
8 hours. The ammonium concentrations of the samples where 20% NH4OH was used for pH 
control were erratic because different amounts of NH4OH were pumped into the medium 
depending on the pH, but the concentration does not steadily decrease over time. Both the growth 
curves (Fig 15) and the ELISA results (Table 7) demonstrate the importance of ammonium in cell 
growth and protein production. An unpaired t test showed that the difference between the final 
ODs of the samples grown using 10% NaOH as a pH control and those of the samples grown 
using 20% NH4OH were statistically significant with a two-tailed P value of 0.0032 (see Table 8). 
Likewise, the difference between the final protein concentrations, as calculated from the ELISA 
results, was statistically significant, with a P value of 0.0096 (see Table 9). FlYS3 is a large 
protein with many repeating amino acids, so it is not surprising that an abundant source of 
nitrogen is necessary for high protein production. 
 
   Table 8.   Statistical analysis of final ODs for NaOH and NH4OH groups,  
   P value = 0.0032 
  NaOH samples NH4OH samples  
Mean 27.933 38.933 
SD 0.503 2.969 
SEM 0.291 1.714 
N 3  3  
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   Table 9.   Statistical analysis of protein concentrations for NaOH and NH4OH  
   groups, P value = 0.0096 
  NaOH samples NH4OH samples  
Mean 666.4167 4716.4433 
SD 1154.2675 966.1241 
SEM 666.4167 557.792 
N 3  3  
 
 
Recommended research 
	  
 Although it was demonstrated that adding additional ammonium to the medium increased 
cell growth and spider silk protein production, the upper threshold of how much ammonium 
could be added was not explored. While ammonium can be toxic for E. coli cells in 
concentrations above 750 mM (13.53 g/L), E. coli cells have been grown with ammonium 
concentrations as high as 500 mM (9.02 g/L) without any detrimental effects to cell growth 
(Müller et al, 2006). The initial ammonium concentration for the cells in this study was about 
75.7 mM (1.37 g/L), so there is potential for increasing the ammonium concentration. It is likely 
that additional ammonium supplementation could further increase the growth rate and protein 
production of the cells.  
While metabolic modeling correctly predicted the need for additional ammonium in the 
cell medium while producing spider silk, it is still a developing field with knowledge gaps. 
Improvements in modeling that are recommended for future research for studies involving 
recombinant protein production are the following: (1) include plasmid information in the model, 
(2) incorporate gene regulation, and (3) incorporate the ability to have more than one objective 
function while using dynamic FBA. As more is leaned about cell metabolism, more information 
can be incorporated into metabolic models. As metabolic models continue to develop with new 
biological discoveries, the predictive capabilities will become even more powerful.  
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Appendix A: Matlab codes 
	  
Dynamic FBA 
 
function [concentrationMatrix,excRxnNames,timeVec,biomassVec] = ... 
    
dynamicFBA(model,substrateRxns,initConcentrations,initBiomass,timeStep,nSteps,p
lotRxns,exclUptakeRxns) 
%dynamicFBA Perform dynamic FBA simulation using the static optimization 
%approach 
% 
% [concentrationMatrix,excRxnNames,timeVec,biomassVec] 
% 
dynamicFBA(model,substrateRxns,initConcentrations,initBiomass,timeStep,nSteps,p
lotRxns,exclUptakeRxns) 
% 
%INPUTS 
% model                 COBRA model structure 
% substrateRxns         List of exchange reaction names for substrates 
%                       initially in the media that may change (e.g. not 
%                       h2o or co2) 
% initConcentrations    Initial concentrations of substrates (in the same 
%                       structure as substrateRxns) 
% initBiomass           Initial biomass (must be non zero) 
% timeStep              Time step size 
% nSteps                Maximum number of time steps 
% 
%OPTIONAL INPUTS 
% plotRxns              Reactions to be plotted (Default = 
%                       {'EX_glc(e)','EX_ac(e)','EX_for(e)'}) 
% exclUptakeRxns        List of uptake reactions whose substrate 
%                       concentrations do not change (Default = 
%                       {'EX_co2(e)','EX_o2(e)','EX_h2o(e)','EX_h(e)'}) 
%  
%OUTPUTS 
% concentrationMatrix   Matrix of extracellular metabolite concentrations 
% excRxnNames           Names of exchange reactions for the EC metabolites 
% timeVec               Vector of time points 
% biomassVec            Vector of biomass values 
% 
% If no initial concentration is given for a substrate that has an open 
% uptake in the model (i.e. model.lb < 0) the concentration is assumed to 
% be high enough to not be limiting. If the uptake rate for a nutrient is 
% calculated to exceed the maximum uptake rate for that nutrient specified 
% in the model and the max uptake rate specified is > 0, the maximum uptake  
% rate specified in the model is used instead of the calculated uptake 
% rate. 
% 
% NOTE: The dynamic FBA method implemented in this function is essentially  
% the same as the method described in 
% [Varma, A., and B. O. Palsson. Appl. Environ. Microbiol. 60:3724 (1994)]. 
% This function does not implement the dynamic FBA using dynamic optimization 
approach 
% described in [Mahadevan, R. et al. Biophys J, 83:1331-1340 (2003)]. 
% 
% Markus Herrgard 8/22/06 
  
if (nargin < 7) 
    plotRxns = {'EX_glc(e)','EX_ac(e)','EX_for(e)'}; 
end 
  
% Uptake reactions whose substrate concentrations do not change 
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if (nargin < 8) 
    exclUptakeRxns = {'EX_co2(e)','EX_o2(e)','EX_h2o(e)','EX_h(e)'}; 
end 
  
% Find exchange rxns 
excInd = findExcRxns(model,false); 
excInd = excInd & ~ismember(model.rxns,exclUptakeRxns); 
excRxnNames = model.rxns(excInd); 
length(excRxnNames) 
% Figure out if substrate reactions are correct 
missingInd = find(~ismember(substrateRxns,excRxnNames)); 
if (~isempty(missingInd)) 
    for i = 1:length(missingInd) 
        fprintf('%s\n',substrateRxns{missingInd(i)}); 
    end 
    error('Invalid substrate uptake reaction!'); 
end 
  
% Initialize concentrations 
substrateMatchInd = ismember(excRxnNames,substrateRxns); 
concentrations = zeros(length(excRxnNames),1); 
concentrations(substrateMatchInd) = initConcentrations; 
  
% Deal with reactions for which there are no initial concentrations 
originalBound = -model.lb(excInd); 
noInitConcentration = (concentrations == 0 & originalBound > 0); 
concentrations(noInitConcentration) = 1000; 
  
biomass = initBiomass; 
  
% Initialize bounds 
uptakeBound =  concentrations/(biomass*timeStep); 
  
% Make sure bounds are not higher than what are specified in the model 
aboveOriginal = (uptakeBound > originalBound) & (originalBound > 0); 
uptakeBound(aboveOriginal) = originalBound(aboveOriginal); 
model.lb(excInd) = -uptakeBound; 
  
concentrationMatrix = sparse(concentrations); 
biomassVec = biomass; 
timeVec(1) = 0; 
  
fprintf('Step number\tBiomass\n'); 
h = waitbar(0,'Dynamic FBA analysis in progress ...'); 
for stepNo = 1:nSteps 
    % Run FBA 
    sol = optimizeCbModel(model,'max','one'); 
    mu = sol.f; 
    if (sol.stat ~= 1 || mu == 0) 
        fprintf('No feasible solution - nutrients exhausted\n'); 
        break; 
    end 
    uptakeFlux = sol.x(excInd); 
    biomass = biomass*exp(mu*timeStep); 
    %biomass = biomass*(1+mu*timeStep); 
    biomassVec(end+1) = biomass; 
     
    % Update concentrations 
    concentrations = concentrations - uptakeFlux/mu*biomass*(1-
exp(mu*timeStep)); 
    %concentrations = concentrations + uptakeFlux*biomass*timeStep; 
    concentrations(concentrations <= 0) = 0; 
    concentrationMatrix(:,end+1) = sparse(concentrations); 
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    % Update bounds for uptake reactions 
    uptakeBound =  concentrations/(biomass*timeStep); 
    % This is to avoid any numerical issues 
    uptakeBound(uptakeBound > 1000) = 1000; 
    % Figure out if the computed bounds were above the original bounds 
    aboveOriginal = (uptakeBound > originalBound) & (originalBound > 0); 
    % Revert to original bounds if the rate was too high 
    uptakeBound(aboveOriginal) = originalBound(aboveOriginal); 
    uptakeBound(abs(uptakeBound) < 1e-9) = 0; 
  
    model.lb(excInd) = -uptakeBound;   
     
    fprintf('%d\t%f\n',stepNo,biomass); 
    waitbar(stepNo/nSteps,h); 
    timeVec(stepNo+1) = stepNo*timeStep; 
end 
if ( regexp( version, 'R20') ) 
        close(h); 
end 
  
selNonZero = any(concentrationMatrix>0,2); 
concentrationMatrix = concentrationMatrix(selNonZero,:); 
excRxnNames = excRxnNames(selNonZero); 
selPlot = ismember(excRxnNames,plotRxns); 
  
% Plot concentrations as a function of time 
clf 
subplot(1,2,1); 
plot(timeVec,biomassVec); 
axis tight 
title('Biomass'); 
subplot(1,2,2); 
plot(timeVec,concentrationMatrix(selPlot,:)); 
axis tight 
legend(strrep(excRxnNames(selPlot),'EX_','')); 
 
Optimize Cb model (FBA) 
 
function FBAsolution = optimizeCbModel(model,osenseStr, minNorm, allowLoops) 
%optimizeCbModel Solve a flux balance analysis problem 
% 
% Solves LP problems of the form: max/min c'*v 
%                                 subject to S*v = b 
%                                            lb <= v <= ub 
% FBAsolution = optimizeCbModel(model,osenseStr,minNormFlag) 
% 
%INPUT 
% model (the following fields are required - others can be supplied) 
%   S            Stoichiometric matrix 
%   b            Right hand side = dx/dt 
%   c            Objective coefficients 
%   lb           Lower bounds 
%   ub           Upper bounds 
% 
%OPTIONAL INPUTS 
% osenseStr      Maximize ('max')/minimize ('min') (opt, default = 'max') 
% 
% minNorm        {(0), 'one', > 0 , n x 1 vector}, where [m,n]=size(S); 
%                0      Default, normal LP 
%                'one'  Minimise the Taxicab Norm using LP. 
%                                 min |v| 
	   47	  
%                                   s.t. S*v = b 
%                                        c'v = f 
%                                        lb <= v <= ub 
%                ----- 
%                The remaining options work only with a valid QP solver: 
%                ----- 
%                > 0    Minimises the Euclidean Norm of internal fluxes. 
%                       Typically 1e-6 works well. 
%                                 min ||v|| 
%                                   s.t. S*v = b 
%                                        c'v = f 
%                                        lb <= v <= ub 
%               n x 1   Forms the diagonal of positive definiate 
%                       matrix F in the quadratic program 
%                               min 0.5*v'*F*v 
%                               st. S*v = b 
%                                   c'*v = f 
%                                   lb <= v <= ub 
% 
% allowLoops    {0,(1)} If true, then instead of a conventional FBA, 
%               the solver will run an MILP version which does not allow 
%               loops in the final solution.  Default is true. 
%               Runs much slower when set to false. 
%               See addLoopLawConstraints.m to for more info. 
% 
%OUTPUT 
% FBAsolution 
%   f         Objective value 
%   x         Primal 
%   y         Dual 
%   w         Reduced costs 
%   s         Slacks 
%   stat      Solver status in standardized form 
%              1   Optimal solution 
%              2   Unbounded solution 
%              0   Infeasible 
%             -1  No solution reported (timelimit, numerical problem etc) 
% 
  
% Markus Herrgard       9/16/03 
% Ronan Fleming         4/25/09  Option to minimises the Euclidean Norm of 
internal 
%                                fluxes using 'cplex_direct' solver 
% Ronan Fleming         7/27/09  Return an error if any imputs are NaN 
% Ronan Fleming         10/24/09 Fixed 'E' for all equality constraints 
% Jan Schellenberger             MILP option to remove flux around loops 
% Ronan Fleming         12/07/09 Reworked minNorm parameter option to allow 
%                                the full range of approaches for getting 
%                                rid of net flux around loops. 
% Jan Schellenberger    2/3/09   fixed bug with .f being set incorrectly 
%                                when minNorm was set. 
% Nathan Lewis          12/2/10  Modified code to allow for inequality 
%                                constraints. 
% Ronan Fleming         12/03/10 Minor changes to the internal handling of 
global parameters. 
%% Process arguments and set up problem 
  
if exist('osenseStr', 'var') 
    if isempty(osenseStr) 
        osenseStr = 'max'; 
    end 
else 
    osenseStr = 'max'; 
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end 
  
if exist('minNorm', 'var') 
    if isempty(minNorm) 
        minNorm = false; 
        changeOK = changeCobraSolverParams('LP','minNorm',minNorm); 
    else 
        changeOK = changeCobraSolverParams('LP','minNorm',minNorm); 
    end 
else 
    minNorm = false; 
    changeOK = changeCobraSolverParams('LP','minNorm',minNorm); 
end 
if exist('allowLoops', 'var') 
    if isempty(allowLoops) 
        allowLoops = true; 
    end 
else 
    allowLoops = true; 
end 
  
[minNorm, printLevel, primalOnlyFlag, saveInput] = 
getCobraSolverParams('LP',{'minNorm','printLevel','primalOnly','saveInput'}); 
  
  
% if exist('minNorm', 'var') 
%     if isempty(minNorm) 
%         minNorm = false; 
%     end 
% else 
%     minNorm = false; 
% end 
% if exist('allowLoops', 'var') 
%     if isempty(allowLoops) 
%         allowLoops = true; 
%     end 
% else 
%     allowLoops = true; 
% end 
%  
%  
% global CBT_LP_PARAMS 
% if (exist('CBT_LP_PARAMS', 'var')) 
%     if isfield(CBT_LP_PARAMS, 'objTol') 
%         tol = CBT_LP_PARAMS.objTol; 
%     else 
%         tol = 1e-6; 
%     end 
%     if isfield(CBT_LP_PARAMS, 'primalOnly') 
%         primalOnlyFlag = CBT_LP_PARAMS.primalOnly; 
%     else 
%         primalOnlyFlag = false; 
%     end 
%     if isfield(CBT_LP_PARAMS, 'printLevel') 
%         printLevel = CBT_LP_PARAMS.printLevel; 
%     else 
%         printLevel = 0; 
%     end 
% else 
%     tol = 1e-6; 
%     primalOnlyFlag = false; 
%     printLevel = 0; 
% end 
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% Figure out objective sense 
if strcmpi(osenseStr,'max') 
    LPproblem.osense = -1; 
else 
    LPproblem.osense = +1; 
end 
  
% this is dangerous... if model does not have S, it should not be called in 
% this function. 
% if ~isfield(model,'S') 
%     model.S=model.A; 
% end 
  
[nMets,nRxns] = size(model.S); 
  
% add csense 
%Doing this makes csense a double array.  Totally smart design move. 
%LPproblem.csense = []; 
if ~isfield(model,'csense') 
    % If csense is not declared in the model, assume that all 
    % constraints are equalities. 
    LPproblem.csense(1:nMets,1) = 'E'; 
else % if csense is in the model, move it to the lp problem structure 
    if length(model.csense)~=nMets, 
        warning('Length of csense is invalid! Defaulting to equality 
constraints.') 
        LPproblem.csense(1:nMets,1) = 'E'; 
    else 
        model.csense = columnVector(model.csense); 
        LPproblem.csense = model.csense; 
    end 
end 
  
  
% Fill in the RHS vector if not provided 
if (~isfield(model,'b')) 
    LPproblem.b = zeros(size(model.S,1),1); 
else 
    LPproblem.b = model.b; 
end 
  
% Rest of the LP problem 
LPproblem.A = model.S; 
LPproblem.c = model.c; 
LPproblem.lb = model.lb; 
LPproblem.ub = model.ub; 
  
%Double check that all inputs are valid: 
if ~(verifyCobraProblem(LPproblem, [], [], false) == 1) 
    warning('invalid problem'); 
    return; 
end 
  
%% 
t1 = clock; 
% Solve initial LP 
if allowLoops 
    solution = solveCobraLP(LPproblem); 
else 
    MILPproblem = addLoopLawConstraints(LPproblem, model, 1:nRxns); 
    solution = solveCobraMILP(MILPproblem); 
end 
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if (solution.stat ~= 1) % check if initial solution was successful. 
    if printLevel>0 
        warning('Optimal solution was not found'); 
    end 
    FBAsolution.f = 0; 
    FBAsolution.x = []; 
    FBAsolution.stat = solution.stat; 
    FBAsolution.origStat = solution.origStat; 
    FBAsolution.solver = solution.solver; 
    FBAsolution.time = etime(clock, t1); 
    return; 
end 
  
objective = solution.obj; % save for later use. 
  
if strcmp(minNorm, 'one') 
    % Minimize the absolute value of fluxes to 'avoid' loopy solutions 
    % Solve secondary LP to minimize one-norm of |v| 
    % Set up the optimization problem 
    % min sum(delta+ + delta-) 
    % 1: S*v1 = 0 
    % 3: delta+ >= -v1 
    % 4: delta- >= v1 
    % 5: c'v1 >= f (optimal value of objective) 
    % 
    % delta+,delta- >= 0 
    LPproblem2.A = [model.S sparse(nMets,2*nRxns); 
        speye(nRxns,nRxns) speye(nRxns,nRxns) sparse(nRxns,nRxns); 
        -speye(nRxns,nRxns) sparse(nRxns,nRxns) speye(nRxns,nRxns); 
        model.c' sparse(1,2*nRxns)]; 
    LPproblem2.c = [zeros(nRxns,1);ones(2*nRxns,1)]; 
    LPproblem2.lb = [model.lb;zeros(2*nRxns,1)]; 
    LPproblem2.ub = [model.ub;10000*ones(2*nRxns,1)]; 
    LPproblem2.b = [LPproblem.b;zeros(2*nRxns,1);solution.obj]; 
    if ~isfield(model,'csense') 
        % If csense is not declared in the model, assume that all 
        % constraints are equalities. 
        LPproblem2.csense(1:nMets) = 'E'; 
    else % if csense is in the model, move it to the lp problem structure 
        if length(model.csense)~=nMets, 
            warning('Length of csense is invalid! Defaulting to equality 
constraints.') 
            LPproblem2.csense(1:nMets) = 'E'; 
        else 
            LPproblem2.csense = columnVector(model.csense); 
        end 
    end 
    LPproblem2.csense((nMets+1):(nMets+2*nRxns)) = 'G'; 
    LPproblem2.csense(nMets+2*nRxns+1) = 'G'; 
    LPproblem2.csense = columnVector(LPproblem2.csense); 
    LPproblem2.osense = 1; 
    % Re-solve the problem 
    if allowLoops 
        solution = solveCobraLP(LPproblem2); %,printLevel,minNorm); 
        solution.dual = []; % slacks and duals will not be valid for this 
computation. 
        solution.rcost = []; 
    else 
        MILPproblem2 = addLoopLawConstraints(LPproblem, model, 1:nRxns); 
        solution = solveCobraMILP(MILPproblem2); 
    end 
elseif length(minNorm)> 1 || minNorm > 0 
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    % quadratic minimization of the norm. 
    % set previous optimum as constraint. 
    LPproblem.A = [LPproblem.A; 
        LPproblem.c']; 
    LPproblem.csense(end+1) = 'E'; 
    if nnz(LPproblem.c)>1 
        error('Code assumes only one non-negative coefficient in linear part of 
objective'); 
    end 
    LPproblem.b = [LPproblem.b;solution.full(LPproblem.c~=0)]; 
    LPproblem.c = zeros(size(LPproblem.c)); % no need for c anymore. 
    %Minimise Euclidean norm using quadratic programming 
    if length(minNorm)==1 
        minNorm=ones(nRxns,1)*minNorm; 
    end 
    LPproblem.F = spdiags(minNorm,0,nRxns,nRxns); 
    %quadratic optimization 
    if allowLoops 
        solution = solveCobraQP(LPproblem); 
    else 
        MIQPproblem = addLoopLawConstraints(LPproblem, model, 1:nRxns); 
        solution = solveCobraMIQP(MIQPproblem); 
    end 
    %     if isempty(solution.full) 
    %         % QP problem did not work.  This will return empty structure 
later. 
    %     else 
    %         %dont include dual variable to additional constraint 
    %         %solution.dual=solution.dual(1:end-1,1); 
    %     end 
end 
  
% Store results 
if (solution.stat == 1) 
    %solution found. 
    FBAsolution.x = solution.full(1:nRxns); 
     
    %this line IS necessary. 
    FBAsolution.f = model.c'*solution.full(1:nRxns); %objective from original 
optimization problem. 
    if abs(FBAsolution.f - objective) > .01 
        display('warning:  objective appears to have changed while performing 
secondary optimization (minNorm)'); 
    end 
     
    if (~primalOnlyFlag && allowLoops && any(~minNorm)) % rcost/dual only 
correct if not doing minNorm 
        FBAsolution.y = solution.dual; 
        FBAsolution.w = solution.rcost; 
    end 
else 
    %some sort of error occured. 
    if printLevel>0 
        warning('Optimal solution was not found'); 
    end 
    FBAsolution.f = 0; 
    FBAsolution.x = []; 
end 
  
FBAsolution.stat = solution.stat; 
FBAsolution.origStat = solution.origStat; 
FBAsolution.solver = solution.solver; 
FBAsolution.time = etime(clock, t1); 
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Dynamic growth simulation 
 
% DynamicGrowthSimulation_new.m 
clear 
  
changeCobraSolver('glpk','LP'); % LP solver set to glpk  
changeCobraSolver('glpk','MILP'); % MILP solver set to glpk  
changeCobraSolver('qpng','QP'); % QP solver set to qpng   
%Read iECD_1391 model 
model = readCbModel('iECD_1391'); 
%Add FlYS3 reaction, change lower bound 
model = addReaction(model,'FlYS3','120 ala-L[c] + 4 asp-L[c] + 522 gly[c] + 12 
his-L[c] + ile-L[c] + lys-L[c] + 2 met-L[c] + 189 pro-L[c] + 111 ser-L[c] + 
thr-L[c] + 78 tyr-L[c] + 4476.3 atp[c] + 4476.3 h2o[c] -> 4476.3 adp[c] + 
4476.3 h[c] + 4476.3 pi[c]'); 
model = changeRxnBounds(model,'FlYS3',0.00336705,'l'); 
%Set objective 
model = changeObjective(model,'Ec_biomass_iJO1366_core_53p95M'); 
%Setting carbon source and oxygen 
model = changeRxnBounds(model,'EX_glc(e)',-11,'l'); 
model = changeRxnBounds(model,'EX_o2(e)',-20,'l'); 
%Setting exchange reactions to zero 
  
model = changeRxnBounds(model,'EX_cbl1(e)',0,'l'); 
model = changeRxnBounds(model,'EX_fe2(e)',0,'l'); 
model = changeRxnBounds(model,'EX_sel(e)',0,'l'); 
model = changeRxnBounds(model,'EX_slnt(e)',0,'l'); 
model = changeRxnBounds(model,'EX_tungs(e)',0,'l'); 
  
%A small amount of flux must go through EX_ca2(e), EX_cobalt2(e), and 
%EX_ni2(e) or the model won't run 
model = changeRxnBounds(model,'EX_ca2(e)',-0.00237348,'l'); 
model = changeRxnBounds(model,'EX_cobalt2(e)',-1.14e-05,'l'); 
model = changeRxnBounds(model,'EX_ni2(e)',-0.000147288,'l'); 
  
%Simulating media conditions 
model = changeRxnBounds(model,'EX_nh4(e)',-6.002150375,'l'); 
model = changeRxnBounds(model,'EX_pi(e)',-5.555386948,'l'); 
model = changeRxnBounds(model,'EX_k(e)',-3.943619038,'l'); 
model = changeRxnBounds(model,'EX_so4(e)',-0.167768684,'l'); 
  
model = changeRxnBounds(model,'EX_cl(e)',-0.138740225,'l'); 
model = changeRxnBounds(model,'EX_cu2(e)',-0.000634963,'l'); 
model = changeRxnBounds(model,'EX_fe3(e)',-0.00696512,'l'); 
model = changeRxnBounds(model,'EX_mg2(e)',-0.160804933,'l'); 
model = changeRxnBounds(model,'EX_mn2(e)',-0.008010947,'l'); 
model = changeRxnBounds(model,'EX_mobd(e)',-0.001508618,'l'); 
model = changeRxnBounds(model,'EX_na1(e)',-0.102668246,'l'); 
model = changeRxnBounds(model,'EX_thm(e)',-0.000746848,'l'); 
model = changeRxnBounds(model,'EX_zn2(e)',-0.001378378,'l'); 
%Amino acids 
model = changeRxnBounds(model,'EX_ala-L(e)',-0.200200247,'l'); 
model = changeRxnBounds(model,'EX_arg-L(e)',-0.065982824,'l'); 
model = changeRxnBounds(model,'EX_asn-L(e)',-0.095998062,'l'); 
model = changeRxnBounds(model,'EX_asp-L(e)',-0.09529124,'l'); 
model = changeRxnBounds(model,'EX_cys-L(e)',-0.013085243,'l'); 
model = changeRxnBounds(model,'EX_gln-L(e)',-0.187137594,'l'); 
model = changeRxnBounds(model,'EX_glu-L(e)',-0.185878393,'l'); 
model = changeRxnBounds(model,'EX_gly(e)',-0.14255367,'l'); 
model = changeRxnBounds(model,'EX_his-L(e)',-0.030655649,'l'); 
model = changeRxnBounds(model,'EX_ile-L(e)',-0.08762833,'l'); 
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model = changeRxnBounds(model,'EX_leu-L(e)',-0.126909995,'l'); 
model = changeRxnBounds(model,'EX_lys-L(e)',-0.119293303,'l'); 
model = changeRxnBounds(model,'EX_met-L(e)',-0.02390703,'l'); 
model = changeRxnBounds(model,'EX_phe-L(e)',-0.05758489,'l'); 
model = changeRxnBounds(model,'EX_pro-L(e)',-0.079180891,'l'); 
model = changeRxnBounds(model,'EX_ser-L(e)',-0.098060253,'l'); 
model = changeRxnBounds(model,'EX_thr-L(e)',-0.089838012,'l'); 
model = changeRxnBounds(model,'EX_tyr-L(e)',-0.039374888,'l'); 
model = changeRxnBounds(model,'EX_val-L(e)',-0.111648451,'l'); 
  
%FOR FBA 
%FBAsolution = optimizeCbModel(model,'max'); 
%printFluxVector(model, FBAsolution.x, true); 
  
% Set-up variables for dynamicFBA 
%NOTE- substrate rxns and plot rxns need to be in the order that they 
%appear in the model 
  
initBiomass = .01; 
timeStep = 0.5; nSteps = 100; 
  
substrateRxns = {'EX_ala-L(e)','EX_arg-L(e)','EX_asn-L(e)','EX_asp-
L(e)','EX_cl(e)','EX_cu2(e)','EX_cys-L(e)','EX_fe3(e)','EX_glc(e)','EX_gln-
L(e)','EX_glu-L(e)','EX_gly(e)','EX_his-L(e)','EX_ile-L(e)','EX_k(e)','EX_leu-
L(e)','EX_lys-L(e)','EX_met-
L(e)','EX_mg2(e)','EX_mn2(e)','EX_mobd(e)','EX_na1(e)','EX_nh4(e)','EX_phe-
L(e)','EX_pi(e)','EX_pro-L(e)','EX_ser-L(e)','EX_so4(e)','EX_thm(e)','EX_thr-
L(e)','EX_tyr-L(e)','EX_val-L(e)','EX_zn2(e)'}; 
initConcentrations = 
[2.525535975,0.832376579,1.211020285,1.202103681,1.750214773,0.008010093,0.1650
70981,0.087865335,138.7655417,2.360749966,2.344865085,1.798321567,0.386722527,1
.105435694,49.74894838,1.600975833,1.504890895,0.301588365,2.028562155,0.101058
487,0.019031286,1.295164976,75.71742258,0.726436225,70.08147994,0.998870842,1.2
37034922,2.11641021,0.009421519,1.133310947,0.496716154,1.408450704,0.017388304
]; 
plotRxns = {'EX_ala-L(e)','EX_arg-L(e)','EX_asn-L(e)','EX_asp-
L(e)','EX_cl(e)','EX_cu2(e)','EX_cys-L(e)','EX_fe3(e)','EX_glc(e)','EX_gln-
L(e)','EX_glu-L(e)','EX_gly(e)','EX_his-L(e)','EX_ile-L(e)','EX_k(e)','EX_leu-
L(e)','EX_lys-L(e)','EX_met-
L(e)','EX_mg2(e)','EX_mn2(e)','EX_mobd(e)','EX_na1(e)','EX_nh4(e)','EX_phe-
L(e)','EX_pi(e)','EX_pro-L(e)','EX_ser-L(e)','EX_so4(e)','EX_thm(e)','EX_thr-
L(e)','EX_tyr-L(e)','EX_val-L(e)','EX_zn2(e)'}; 
  
dynamicFBA(model,substrateRxns,initConcentrations, initBiomass, timeStep, 
nSteps, plotRxns); 
%labeling 
subplot(1,2,1); 
title('Growth rate'); 
xlabel('Time steps'); 
ylabel('g biomass/gDW*h'); 
subplot(1,2,2); 
title('Substrate Concentrations'); 
xlabel('Time steps'); 
ylabel('Concentrations (mmol/L)'); 
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Appendix B: Recipes and protocols 
Yeast-Hy ES II medium 
	  
Initial medium:  
Yeast Extract 5 g/L 
Hy-ES II 15g/L 
  
After autoclaved add:  
Glycerol 16g/L 
Glucose 25g/L 
Trace element 1 1.5ml 
Trace element 2 1.5ml 
x20 N.P.S stock 50ml 
0.5g/ml MgSO4 1ml 
5mg/ml Thiamine 0.8ml 
  
Trace element 1  
CuSO4.5H2O 0.25g/100ml 
MnSO4.H2O 2.4g/100ml 
Na2MoO4.2H2O 0.30g/100ml 
Ni(NO3)2 2.5g/100ml 
ZnSO4 1.5ml/100ml 
6N H2SO4 0.3ml/100ml 
  
Trace element 2  
NaCl 0.5g/100ml 
FeCl3.6H2O 0.475g/100ml 
CoCl2.6H2O 0.075g/100ml 
H3BO3 0.05g/100ml 
CaCl2.2H2O 0.29g/100ml 
6N H2SO4 0.3ml/100ml 
  
x20 N.P.S. stock solution  
(NH4)2SO4 66g/L 
KH2PO4 136g/L 
NaH2PO4 142g/L 
 
 
 
K12 medium and K12 trace metal solution 
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Initial medium:  
KH2PO4 2g/L 
K2HPO4.3H2O 4g/L 
(NH4)2HPO4 5g/L 
Yeast Extract 5g/L 
  
After autoclaved add: 
Glucose 25g/L 
MgSO4.7H2O 0.5g/L 
Thiamine 2.5mg/L 
K12 trace metal 5 ml/L 
 
K12 trace metal solution 
NaCl 5 g/L 
ZnSO4.7H2O 1 g/L 
MnCl2.4H2O 4 g/L 
FeCl3.6H2O 4.75 g/L 
CuSO4.5H2O 0.4 g/L 
H3BO3 0.575 g/L 
NaMoO4.2H2O 0.5 g/L 
6N H2SO4 12.5 ml/L 
Sterilize with 0.2 µm syringe 
filter 
 
Glucose feeding solution 
	  
Glucose 500g/L 
MgSO4.7H2O 10g/L 
Thiamine 40mg/L 
K12 trace metal 5ml/L 
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Q-Plex array: anti poly-histidine kit 
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Western blot 
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Appendix C: Sequence information 
	  
FlYS3 sequence 
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Plasmid Modification 
 
The pET19k-SX FlYS3 plasmid was used in this study. The pET19k-SX FlYS3 plasmid 
is a modified form of the pET-19b plasmid (See Fig 18).  
 
Figure 18.   Vector map of pET-19b.  
 
 
The modifications are as follows. The section AlwN I to Bpu1102 I was removed from 
pET19b, and the remaining large fragment was purified. The fragment AlwN I to Bpu1102 I from 
the plasmid pET-26b (see Fig 19) was then ligated into the large purified fragment, creating 
vector pET-19k (see Fig 20).  
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Figure 19.   Vector map of pET-26b. Obtained from Dr. Randy Lewis. 
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Figure 20.   Vector map of pET-19k. Obtained from Dr. Randy Lewis. 
 
 
Bgl II to Sph I was then replaced with SHMT (Serine hydroxylmethyltransferase) and 
GlyT, ProL, and ProM (tRNAs for glycine and two prolines). To reduce the size of the plasmid, a 
non-critical region between PshA I (blunt-ended GACNN/NNGTC) at bp 2070 of the original 
pET19b sequence and Hpy166 II (blunt-ended, GTN/NAC) at bp 3599 of the original pET19b 
sequence was excised. The resulting vector is known as pET19-SX, as shown in Fig 21. An insert 
containing 3 multiples of a 1000 bp fragment of flagelliform silk known as FlYS3 was inserted 
between NdeI and BamHI, creating the pET19k-SX-FlYS3 vector. 
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Figure 21. Vector map of pET19-SX. Obtained from Dr. Randy Lewis. 
 
 
 
 
 
 
 
 
 
pET19-­‐SX	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Plasmid Sequence 
 
The amino acid sequence for pET19k-SX (6209 bp), obtained from Dr. Randy Lewis, is 
as follows:  
ATCCGGATATAGTTCCTCCTTTCAGCAAAAAACCCCTCAAGACCCGTTTAGAGGCCCCAAGGG
GTTATGCTAGTTATTGCTCAGCGGTGGCAGCAGCCAACTCAGCTTCCTTTCGGGCTTTGTTAGC
AGCCGGATCCTCGAGCATATGCTTGTCGTCGTCGTCGATATGGCCGCTGCTGTGATGATGATG
ATGATGATGATGATGATGGCCCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAG
AGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAG
ATCTGACCTGTTATCGCACAATGATTCGGTTATACTGTTCGCCGTTGTCCAACAGGACCGCCTA
TAAAGGCCAAAAATTTTATTGTTAGCTGAGTCAGGAGATGCGGATGTTAAAGCGTGAAATGA
ACATTGCCGATTATGATGCCGAACTGTGGCAGGCTATGGAGCAGGAAAAAGTACGTCAGGAA
GAGCACATCGAACTGATCGCCTCCGAAAACTACACCAGCCCGCGCGTAATGCAGGCGCAGGG
TTCTCAGCTGACCAACAAATATGCTGAAGGTTATCCGGGCAAACGCTACTACGGCGGTTGCGA
GTATGTTGATATCGTTGAACAACTGGCGATCGATCGTGCGAAAGAACTGTTCGGCGCTGACTA
CGCTAACGTCCAGCCGCACTCCGGCTCCCAGGCTAACTTTGCGGTCTACACCGCGCTGCTGGA
ACCAGGTGATACCGTTCTGGGTATGAACCTGGCGCATGGCGGTCACCTGACTCACGGTTCTCC
GGTTAACTTCTCCGGTAAACTGTACAACATCGTTCCTTACGGTATCGATGCTACCGGTCATATC
GACTACGCCGATCTGGAAAAACAAGCCAAAGAACACAAGCCGAAAATGATTATCGGTGGTTT
CTCTGCATATTCCGGCGTGGTGGACTGGGCGAAAATGCGTGAAATCGCTGACAGCATCGGTGC
TTACCTGTTCGTTGATATGGCGCACGTTGCGGGCCTGGTTGCTGCTGGCGTCTACCCGAACCCG
GTTCCTCATGCTCACGTTGTTACTACCACCACTCACAAAACCCTGGCGGGTCCGCGCGGCGGC
CTGATCCTGGCGAAAGGTGGTAGCGAAGAGCTGTACAAAAAACTGAACTCTGCCGTTTTCCCT
GGTGGTCAGGGCGGTCCGTTGATGCACGTAATCGCCGGTAAAGCGGTTGCTCTGAAAGAAGC
GATGGAGCCTGAGTTCAAAACTTACCAGCAGCAGGTCGCGAAAAACGCTAAAGCGATGGTAG
AAGTGTTCCTCGAGCGCGGCTACAAAGTGGTTTCCGGCGGCACTGATAACCACCTGTTCCTGG
TTGATCTGGTTGATAAAAACCTGACCGGTAAAGAAGCAGACGCCGCTCTGGGCCGTGCTAAC
ATCACCGTCAACAAAAACAGCGTACCGAACGATCCGAAGAGCCCGTTTGTGACCTCCGGTATT
CGCGTGGGTACTCCGGCAATTACGCGTCGCGGCTTCAAAGAAGCAGAAGCGAAAGAACTGGC
TGGCTGGATGTGTGACGTGCTGGACAGCATCAATGATGAAGCCGTTATCGAGCGCATCAAAG
GTAAAGTTCTCGACATCTGCGCACGTTACCCGGTTTACGCATAAGCGAAACGGTGATTTGCTG
ACAATGTGCTCGTTGTTCATGTTGGATGCGGCATGAACACGTCGACCGTAGCCCGAGACGATA
AGTTCGCTTACCGGCTCGAATGAAGAGAGCTTCTCTCGATATTCAGTGCAGAATGAAAATCAG
GTAGCCGAGTTCCAGGATGCGGGCATCGTATAATGGCTATTACCTCAGCCTTCCAAGCTGATG
ATGCGGGTTCGATTCCCGCTGCCCGCTCCAAGATGTGCTGATATAGCTCAGTTGGTAGAGCGC
ACCCTTGGTAAGGGTGAGGTCGGCAGTTCGAATCTGCCTATCAGCACCACTTCTTTTCTCCTCC
CTGTTTTTTCCTTCTGTTTATTGCATTCAACAAGTCGGGCATGTTGCAAGCTTCTTGCAATCGGT
GTGGAAAACGGTAGTATTAGCAGCCACGAGTCGGCACGTAGCGCAGCCTGGTAGCGCACCGT
CATGGGGTGTCGGGGGTCGGAGGTTCAAATCCTCTCGTGCCGACCAAAAATCCCAAGAAAAA
ACCAACCCTTACGGTTGGTTTTTTTATATCTGCAATTAATTCGATAAACAGACCGTGACACATC
ACGAATTCCTCGCACCACGACTTTAAAGAATTGAACTAAAAATTCAAAAAGCAGTATTTCGGC
GAGTAGCGCAGCTTGGTAGCGCAACTGGTTTGGGACCAGTGGGTCGGAGGTTCGAATCCTCTC
TCGCCGACCAATTTTGAACCCCGCTTCGGCGGGGTTTTTTGTTTTCTGTGCATTTCGTCACTTTC
CCGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTC
CTAATGCAGGAGTCGCATAAGGGAGAGCGTCGAGATCCCGGACACCATCGAATGGCGCAAAA
CCTTTCGCGGTATGGCATGATAGCGCCCGGAAGAGAGTCAATTCAGGGTGGTGAATGTGAAA
CCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTG
GTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCGG
AGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTG
GCGTTGCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTC
GCGCCGATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCC
TGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCG
CTGGATGACCAGGATGCCATTGCTGTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTG
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ATGTCTCTGACCAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACTGG
GCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTTAGCGGGCCCATTAAGTT
CTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATATCTCACTCGCAATCAAATTCAGC
CGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATG
CTGAATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCGCTGGGCGCA
ATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATACGAC
GATACCGAAGACAGCTCATGTTATATCCCGCCGTTAACCACCATCAAACAGGATTTTCGCCTG
CTGGGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAA
TCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAACCGC
CTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAG
CGGGCAGTGAGCGCAACGCAATTAATGTAAGTTAGCTCACTCATTAGGCACCGGGATCTCGAC
CGATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTAATA
CTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATATGCGGTGTGAA
ATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACT
GACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATA
CGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAA
AGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACG
AGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC
CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGAT
ACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCT
CAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGA
CCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCC
ACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGT
TCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTG
GTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAA
GATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATT
TTGGTCATGAACAATAAAACTGTCTGCTTACATAAACAGTAATACAAGGGGTGTTATGAGCCA
TATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATA
TGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGG
GAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTAC
AGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTT
TATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCA
GGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCG
CCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTC
AGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATG
GCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAG
TCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTG
TATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTG
CCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCT
GATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGAATTAATTCATGAGC
GGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGA
AAAGTGCCACCTGAAATTGTAAACGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAA
TCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGA
CCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACT
CCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCC
TAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCC
CGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGA
AAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCC
GCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCA 
 
 
